teva logo 88.
(photo credit: )
Teva Pharmeceutical Industries said Sunday it expects to close its acquisition of Ivax Corporation by January 12.
Teva agreed to buy Ivax in July for $7.4 billion, the largest ever acquisition by an Israeli company.
The companies said they have signed a consent order for submission to the US Federal Trade Commision (FTC) which is "the last remaining regulatory condition to the consummation of the transaction."